Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

Related Articles by Review for PubMed (Select 19252159)

1.

Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults.

McCarthy S, Asherson P, Coghill D, Hollis C, Murray M, Potts L, Sayal K, de Soysa R, Taylor E, Williams T, Wong IC.

Br J Psychiatry. 2009 Mar;194(3):273-7. doi: 10.1192/bjp.bp.107.045245.

2.

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.

PMID:
19445548
3.

A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents.

King S, Griffin S, Hodges Z, Weatherly H, Asseburg C, Richardson G, Golder S, Taylor E, Drummond M, Riemsma R.

Health Technol Assess. 2006 Jul;10(23):iii-iv, xiii-146. Review.

4.

[Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].

Purper-Ouakil D, Fourneret P, Wohl M, Rénéric JP.

Encephale. 2005 May-Jun;31(3):337-48. Review. French.

PMID:
16142049
5.

Attention-deficit-hyperactivity disorder: an update.

Dopheide JA, Pliszka SR.

Pharmacotherapy. 2009 Jun;29(6):656-79. doi: 10.1592/phco.29.6.656. Review.

PMID:
19476419
7.

Medication options when treating children and adolescents with ADHD: interpreting the NICE guidance 2006.

Harpin VA.

Arch Dis Child Educ Pract Ed. 2008 Apr;93(2):58-65. doi: 10.1136/adc.2006.106864. Review.

PMID:
18356307
8.
9.

Pharmacological and clinical dilemmas of prescribing in co-morbid adult attention-deficit/hyperactivity disorder and addiction.

Pérez de los Cobos J, Siñol N, Pérez V, Trujols J.

Br J Clin Pharmacol. 2014 Feb;77(2):337-56. doi: 10.1111/bcp.12045. Review.

10.

Update on drugs for hyperactivity in childhood.

[No authors listed]

Drug Ther Bull. 2007 May;45(5):37-40. Review. Erratum in: Drug Ther Bull. 2007 Nov;45(11):88. Drug Ther Bull. 2007 Aug;45(8):64.

PMID:
17536494
11.

Attention deficit hyperactivity disorder in the European adult population: prevalence, disease awareness, and treatment guidelines.

Ramos-Quiroga JA, Montoya A, Kutzelnigg A, Deberdt W, Sobanski E.

Curr Med Res Opin. 2013 Sep;29(9):1093-104. doi: 10.1185/03007995.2013.812961. Epub 2013 Jul 2. Review. Erratum in: Curr Med Res Opin. 2013 Nov;29(11):1573.

PMID:
23742051
12.

Clinical considerations for the diagnosis and treatment of ADHD in the managed care setting.

Jensen PS.

Am J Manag Care. 2009 May;15(5 Suppl):S129-40. Review.

13.

Beyond the 'typical' patient: treating attention-deficit/hyperactivity disorder in preschoolers and adults.

Vaughan BS, Wetzel MW, Kratochvil CJ.

Int Rev Psychiatry. 2008 Apr;20(2):143-9. doi: 10.1080/09540260801887751. Review.

PMID:
18386204
14.

Atomoxetine, a novel treatment for attention-deficit-hyperactivity disorder.

Christman AK, Fermo JD, Markowitz JS.

Pharmacotherapy. 2004 Aug;24(8):1020-36. Review.

PMID:
15338851
15.
16.

Priapism associated with the use of stimulant medications and atomoxetine for attention-deficit/hyperactivity disorder in children.

Eiland LS, Bell EA, Erramouspe J.

Ann Pharmacother. 2014 Oct;48(10):1350-5. doi: 10.1177/1060028014541791. Epub 2014 Jun 30. Review.

PMID:
24982313
17.

[Diagnosis and treatment of attention deficit hyperactivity disorder in adults].

Ramos-Quiroga JA, Chalita PJ, Vidal R, Bosch R, Palomar G, Prats L, Casas M.

Rev Neurol. 2012 Feb 29;54 Suppl 1:S105-15. Review. Spanish.

18.
19.

[Attention deficit hyperactivity disorder in adults: a clinical and therapeutic characterization].

Ramos-Quiroga JA, Bosch-Munsó R, Castells-Cervelló X, Nogueira-Morais M, García-Gimenez E, Casas-Brugué M.

Rev Neurol. 2006 May 16-31;42(10):600-6. Review. Spanish.

20.

Advances in the treatment of attention-deficit/hyperactivity disorder: a guide for pediatric neurologists.

Wigal SB, Chae S, Patel A, Steinberg-Epstein R.

Semin Pediatr Neurol. 2010 Dec;17(4):230-6. doi: 10.1016/j.spen.2010.10.005. Review.

PMID:
21183129
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk